Literature DB >> 32388910

Oncogenic circular RNA Hsa-circ-000684 interacts with microRNA-186 to upregulate ZEB1 in gastric cancer.

Sen Lin1, Suzhen Song2, Rong Sun3, Mingbao Zhang1, Yating Du1, Dongdong Zhang1, Weihua Xu1, Hongbo Wang1.   

Abstract

Circular RNAs (circRNAs) function as modulators of microRNAs (miRNAs) and are often involved in cancer progression. This study aims to investigate the underlying mechanism by which circRNA hsa-circ-000684 promotes the progression of gastric cancer (GC). Expression of hsa-circ-000684 and that of ZEB1 mRNA were elevated while microRNA-186 (miR-186) expression was downregulated in GC cell lines and clinical tissues. In addition, the effects of hsa-circ-000684 on the proliferation, migration, invasion, and tube formation of GC cells were examined through gain-and loss-of-function experiments. Furthermore, we introduced tumor xenografts into nude mice to better understand these effects in vivo. Either knockdown of hsa-circ-000684 or upregulation of miR-186 inhibited GC cell proliferation, migration, invasion, and tube formation in vitro, and reduced the xenograft tumor growth in nude mice. Moreover, we found that hsa-circ-000684 and ZEB1 directly bound to miR-186. Hsa-circ-000684 increased the expression of ZEB1 by binding to miR-186. The tumor suppressive effects of hsa-circ-000684 knockdown were reversed by inhibition of miR-186. Collectively, our data show that hsa-circ-000684 reduces the miR-186 expression which leads to an increase in the ZEB1 expression and, consequently, promotion of GC progression.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  ZEB1; angiogenesis; circular RNA hsa-circ-000684; gastric cancer; microRNA-186

Year:  2020        PMID: 32388910     DOI: 10.1096/fj.201903246R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer.

Authors:  Yuting Xu; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Hua Cao; Wei Qiu; Qiang Tu; Fei Mao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes.

Authors:  Michaela Dostalova Merkerova; Jiri Klema; David Kundrat; Katarina Szikszai; Zdenek Krejcik; Andrea Hrustincova; Iva Trsova; Anh Vu LE; Jaroslav Cermak; Anna Jonasova; Monika Belickova
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

Review 3.  Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets.

Authors:  Jiafeng Ouyang; Zhi Long; Guoqing Li
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

Review 4.  The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs.

Authors:  Lele Zhang; Chaofeng Hou; Chen Chen; Yaxin Guo; Weitang Yuan; Detao Yin; Jinbo Liu; Zhenqiang Sun
Journal:  Mol Cancer       Date:  2020-06-10       Impact factor: 27.401

5.  Hsa_circ_0046263 Drives the Carcinogenesis and Metastasis of Non-Small Cell Lung Cancer Through the Promotion of NOVA2 by Absorbing Mir-940 as a Molecular Sponge.

Authors:  Guanghui Li; Chunsheng Zhao; Haining Zhang; Jia Yu; Yang Sun; Yingying Zhang
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

Review 6.  Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.

Authors:  Hashem Khanbabaei; Saeedeh Ebrahimi; Juan Luis García-Rodríguez; Zahra Ghasemi; Hossein Pourghadamyari; Milad Mohammadi; Lasse Sommer Kristensen
Journal:  J Exp Clin Cancer Res       Date:  2022-09-16

7.  Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p.

Authors:  Zhipeng Zhang; Yikai Zhou; Na Zhou; Junda Yin; Xuechun Kuang
Journal:  J Gastrointest Oncol       Date:  2022-08

Review 8.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.